Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 233,298,455 papers from all fields of science
Search
Sign In
Create Free Account
MS 325
Known as:
MS-325
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
Broader (1)
gadofosveset trisodium
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2011
2011
Gd complexes of macrocyclic diethylenetriaminepentaacetic acid (DTPA) biphenyl-2,2'-bisamides as strong blood-pool magnetic resonance imaging contrast agents.
Ki-Hye Jung
,
Hee-Kyung Kim
,
+5 authors
Tae-Jeong Kim
Journal of Medicinal Chemistry
2011
Corpus ID: 25621811
We report the synthesis of macrocyclic DTPA conjugates of 2,2'-diaminobiphenyl and their Gd complexes of the type [Gd(L)(H(2)O…
Expand
2007
2007
MS 325 zur Darstellung des ischämisch geschädigten Myokards
G. Krombach
,
M. Gockel
,
Y. Temur
,
A. Bücker
,
C. Hohl
,
R. Günther
2007
Corpus ID: 71786691
Ziele: Erprobung des intravaskularen Kontrastmittels MS-325 (Vasovist, Schering, Berlin) zur Darstellung infarzierten Myokards…
Expand
2006
2006
MR-koronarangiographie mit MS-325, einem Blood-Pool-Kontrastmittel : Vergleich einer Inversion Recovery Steady-State Free Precession und einer Inversion Recovery Fast Low Angle Shot Sequenz in…
K. Nassenstein
,
K. Waltering
,
H. Eggebrecht
,
T. Schlosser
,
P. Hunold
,
J. Barkhausen
2006
Corpus ID: 71346142
PURPOSE: To compare the signal-to-noise and contrast-to-noise ratio as well as the image quality of 3D inversion recovery steady…
Expand
2006
2006
[MR coronary angiography with MS-325, a blood pool contrast agent: comparison of an inversion recovery steady-state free precession with an inversion recovery fast low angle shot sequence in…
K. Nassenstein
,
K. Waltering
,
H. Eggebrecht
,
T. Schlosser
,
P. Hunold
,
J. Barkhausen
RöFo. Fortschritte auf dem Gebiet der R…
2006
Corpus ID: 20978627
PURPOSE To compare the signal-to-noise and contrast-to-noise ratio as well as the image quality of 3D inversion recovery steady…
Expand
2005
2005
When are two waters worse than one? Doubling the hydration number of a Gd-DTPA derivative decreases relaxivity.
P. Caravan
,
J. Amedio
,
+9 authors
R. Lauffer
Chemistry
2005
Corpus ID: 24629415
The synthesis of a novel ligand, based on N-methyl-diethylenetriaminetetraacetate and containing a diphenylcyclohexyl serum…
Expand
2001
2001
Magnetic resonance angiography at 0.3 T using MS-325
K. M. Lahti
,
R. Lauffer
,
T. Chan
,
R. Weisskoff
Magnetic Resonance Materials in Physics, Biology…
2001
Corpus ID: 12028759
Preliminary results on MS-325 versus ProHance enhanced magnetic resonance angiography (MRA) at low field strength in a rabbit…
Expand
2000
2000
MS-325 EPIX.
Mahfouz Ae
2000
Corpus ID: 134460259
EPIX is developing MS-325 (AngioMARK), an intravascular magnetic resonance contrast agent for use in the imaging of blood vessels…
Expand
2000
2000
MS-325 EPIX.
A. E. Mahfouz
Current opinion in investigational drugs
2000
Corpus ID: 22168610
EPIX is developing MS-325 (AngioMARK), an intravascular magnetic resonance contrast agent for use in the imaging of blood vessels…
Expand
2000
2000
Lecture 3 Dynamic MR imaging of the female genitalia using AngioMARK: initial experience evaluating the female sexual response
A. Deliganis
,
K. Maravilla
,
+6 authors
UP Schmiedl
International journal of impotence research
2000
Corpus ID: 21604125
Serial high resolution MR imaging (3D SPGR, 11=1.7=35) of the perineum was performed in sixteen healthy, sexually functional…
Expand
Review
1997
Review
1997
Macromolecular contrast media. A new approach for characterising breast tumors with MR-mammography
H. Daldrup
,
T. Roberts
,
+5 authors
R. Brasch
Der Radiologe
1997
Corpus ID: 23015040
SummeryThe value of macromolecular contrast agents (MMCM) for the characterization of benign and malignant breast tumors will be…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE